-
1341por McDougall, N. I., McCluggage, W. G., Coyle, P. V., Sloan, J. M., Callender, M. E.“…Chronic hepatitis C virus (HCV) infection has become a major health problem affecting an estimated 170 million people worldwide. …”
Publicado 2004
Enlace del recurso
Enlace del recurso
Texto -
1342por Negro, Francesco“…Insulin resistance and type 2 diabetes are associated with hepatitis C virus infection. A wealth of clinical and experimental data suggests that the virus is directly interfering with the insulin signalling in hepatocytes. …”
Publicado 2009
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
1343
-
1344por Jamieson, Denise J., Skunodom, Natapakwa, Chaowanachan, Thanyanan, Roongpisuthipong, Anuvat, Bower, William A., Chotpitayasunondh, Tawee, Bhanich Supapol, Wendy, Kuhnert, Wendi L., Siriwasin, Wimol, Wiener, Jeffrey, Chearskul, Sanay, McConnell, Michelle S., Shaffer, Nathan“…The purpose of this study was to describe the epidemiology of coinfection with hepatitis C virus (HCV) and HIV among a cohort of pregnant Thai women. …”
Publicado 2008
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
1345por Wang, Jane H, Zheng, Xin, Ke, Xiaogang, Dorak, M Tevfik, Shen, Jingjing, Boodram, Basmattee, O'Gorman, Maurice, Beaman, Kenneth, Cotler, Scott J, Hershow, Ronald, Rong, Lijun“…BACKGROUNDS: The association of human leukocyte antigen (HLA) genes with the outcome of hepatitis C virus (HCV) infection may be modified by ethnic and geographical differences. …”
Publicado 2009
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
1346por Danish, Fazal A., Koul, Salman S., Subhani, Fazal R., Rabbani, Ahemd E., Yasmin, Saeeda“…Drug-induced hematotoxicity is the most common reason for reducing the dose or withdrawing ribavirin (RBV) and interferon (IFN) therapy in chronic hepatitis C, which leads to the elimination of a possible cure for the patient. …”
Publicado 2008
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
1347
-
1348“…BACKGROUND: Patients chronically infected with hepatitis C virus (HCV) require significantly different durations of therapy and achieve substantially different sustained virologic response rates to interferon-based therapies, depending on the HCV genotype with which they are infected. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
1349“…In 2005, the first robust hepatitis C virus (HCV) infectious cell culture system was developed based on the HCV genotype 2a JFH-1 molecular clone and the human-derived hepatoma cell line Huh7. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
1350por Idrees, Muhammad, Butt, Sadia, Awan, Zunaira, Aftab, Mahwish, Khubaib, Bushra, Rehman, Irshad-ur, Akram, Madiha, Manzoor, Sobia, Akbar, Haji, Rafiqe, Shazia, Riazuddin, Sheikh“…BACKGROUND: The variability within the hepatitis C virus (HCV) genome has formed the basis for several genotyping methods and used widely for HCV genotyping worldwide. …”
Publicado 2009
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
1351“…Poor and non-white patients are disproportionately infected with the hepatitis C virus (HCV). The objective of this research is to determine sociodemographic patterns of HCV-related ambulatory care visits over time. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
1352por Moreno, Pilar, Alvarez, Macarena, López, Lilia, Moratorio, Gonzalo, Casane, Didier, Castells, Matías, Castro, Silvia, Cristina, Juan, Colina, Rodney“…BACKGROUND/AIM: Hepatitis C virus (HCV) infection is an important cause of morbidity and mortality in patients affected by hereditary bleeding disorders. …”
Publicado 2009
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
1353por Seo, Yeon Seok, Jung, Eun Suk, Kim, Jeong Han, Jung, Young Kul, Kim, Ji Hoon, An, Hyonggin, Yim, Hyung Joon, Yeon, Jong Eun, Byun, Kwan Soo, Kim, Chang Duck, Ryu, Ho Sang, Um, Soon Ho“…BACKGROUND/AIMS: Hepatitis C virus (HCV) RNA testing can be performed using qualitative or quantitative assays, and it is still unclear which is more useful as a primary test in patients positive for anti-HCV. …”
Publicado 2009
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
1354por Coller, Kelly E., Berger, Kristi L., Heaton, Nicholas S., Cooper, Jacob D., Yoon, Rosa, Randall, Glenn“…Hepatitis C virus (HCV) enters hepatocytes following a complex set of receptor interactions, culminating in internalization via clathrin-mediated endocytosis. …”
Publicado 2009
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
1355por Klevens, R. Monina, Miller, Jeremy, Vonderwahl, Candace, Speers, Suzanne, Alelis, Karen, Sweet, Kristin, Rocchio, Elena, Poissant, Tasha, Vogt, Tara M., Gallagher, Kathleen“…Surveillance for hepatitis C virus infection in 6 US sites identified 20,285 newly reported cases in 12 months (report rate 69 cases/100,000 population, range 25–108/100,000). …”
Publicado 2009
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
1356por Sosa-Jurado, Francisca, Santos-López, Gerardo, Guzmán-Flores, Belinda, Ruiz-Conde, Julia I, Meléndez-Mena, Daniel, Vargas-Maldonado, Martín T, Martínez-Laguna, Ygnacio, Contreras-Mioni, Laura, Vallejo-Ruiz, Verónica, Reyes-Leyva, Julio“…The objective of present study was to analyze the prevalence of antibodies and genotypes of hepatitis C virus (HCV) in blood donors from Puebla, Mexico. …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
1357“…This, along with transplantation, has drastically changed the course of hepatitis C virus (HCV) infection over the last two decades. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
1358
-
1359por Owens, Christopher M, Mawhinney, Christina, Grenier, Jill M, Altmeyer, Ralf, Lee, Margaret S, Borisy, Alexis A, Lehár, Joseph, Johansen, Lisa M“…The search for effective Hepatitis C antiviral therapies has recently focused on host sterol metabolism and protein prenylation pathways that indirectly affect viral replication. …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
1360por González-Candelas, Fernando, Guiral, Silvia, Carbó, Rosa, Valero, Ana, Vanaclocha, Hermelinda, González, Francisco, Bracho, Maria Alma“…BACKGROUND: No recognized risk factors can be identified in 10-40% of hepatitis C virus (HCV)-infected patients suggesting that the modes of transmission involved could be underestimated or unidentified. …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto